Trial intelligence / Profile preview

Granisetron versus ondansetron for nausea and vomiting in adult emergency department patients

IRCT20191007045013N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Nausea and Vomiting comparing Ondansetron arm with Granisetron arm (2 arms). Primary endpoint: Nausea and vomiting. Started Jan 2020; status: completed.

02

Drugs

granisetronondansetron
03

Conditions

Nausea and Vomiting

Beyond the preview

Go deeper on IRCT20191007045013N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191007045013N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call